Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Onesource Specialty Pharma: Board Meeting Intimation for Approval Of The Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025
News Announcement

Onesource Specialty Pharma: Board Meeting Intimation for Approval Of The Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025

29-Jul-2025 Follow Value Research Online on Google download pdfDownload PDF Onesource Specialty Pharma

Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 inter alia to consider and approve the standalone and consolidated financial results for the quarter ended June 30 2025

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds